Robert Ramer

2.8k total citations
54 papers, 2.3k citations indexed

About

Robert Ramer is a scholar working on Pharmacology, Molecular Biology and Surgery. According to data from OpenAlex, Robert Ramer has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pharmacology, 22 papers in Molecular Biology and 17 papers in Surgery. Recurrent topics in Robert Ramer's work include Cannabis and Cannabinoid Research (34 papers), Pancreatic function and diabetes (15 papers) and Diet, Metabolism, and Disease (10 papers). Robert Ramer is often cited by papers focused on Cannabis and Cannabinoid Research (34 papers), Pancreatic function and diabetes (15 papers) and Diet, Metabolism, and Disease (10 papers). Robert Ramer collaborates with scholars based in Germany, United States and Czechia. Robert Ramer's co-authors include Burkhard Hinz, Jutta Merkord, Kay Brune, Michael Linnebacher, Maria Haustein, Achim Salamon, Katrin Manda, Kirsten Peters, Igor Ivanov and U. Walther and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and Scientific Reports.

In The Last Decade

Robert Ramer

53 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Ramer Germany 29 1.6k 670 492 333 316 54 2.3k
Mar Lorente Spain 24 1.6k 1.0× 955 1.4× 565 1.1× 386 1.2× 181 0.6× 29 2.8k
Sean D. McAllister United States 23 1.8k 1.2× 875 1.3× 422 0.9× 350 1.1× 175 0.6× 43 2.7k
Teresa Gómez del Pulgar Spain 23 1.8k 1.2× 1.0k 1.5× 442 0.9× 354 1.1× 179 0.6× 36 3.1k
Marya Liimatta United States 19 871 0.6× 852 1.3× 364 0.7× 109 0.3× 252 0.8× 23 2.0k
Martin Kaczocha United States 27 1.8k 1.2× 795 1.2× 286 0.6× 193 0.6× 328 1.0× 69 2.7k
Sonia Hernández‐Tiedra Spain 15 816 0.5× 520 0.8× 265 0.5× 237 0.7× 86 0.3× 15 1.6k
Anju Preet United States 15 468 0.3× 639 1.0× 174 0.4× 112 0.3× 123 0.4× 21 1.3k
Gregory I. Liou United States 35 449 0.3× 1.6k 2.3× 157 0.3× 136 0.4× 294 0.9× 61 3.6k
David J. Behm United States 26 591 0.4× 415 0.6× 573 1.2× 42 0.1× 362 1.1× 47 1.6k
Odette Laneuville Canada 26 928 0.6× 599 0.9× 435 0.9× 26 0.1× 82 0.3× 78 2.3k

Countries citing papers authored by Robert Ramer

Since Specialization
Citations

This map shows the geographic impact of Robert Ramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Ramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Ramer more than expected).

Fields of papers citing papers by Robert Ramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Ramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Ramer. The network helps show where Robert Ramer may publish in the future.

Co-authorship network of co-authors of Robert Ramer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Ramer. A scholar is included among the top collaborators of Robert Ramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Ramer. Robert Ramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bekeschus, Sander, et al.. (2024). β-Caryophyllene Inhibits Endothelial Tube Formation by Modulating the Secretome of Hypoxic Lung Cancer Cells—Possible Role of VEGF Downregulation. International Journal of Molecular Sciences. 25(2). 810–810. 6 indexed citations
4.
Rupprecht, Anne, Robert Ramer, Peter Langer, et al.. (2023). A Thia-Analogous Indirubin N-Glycoside Disrupts Mitochondrial Function and Causes the Death of Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells. Cells. 12(19). 2409–2409. 2 indexed citations
5.
Bekeschus, Sander, et al.. (2023). Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells. Cells. 12(19). 2332–2332. 2 indexed citations
6.
Ramer, Robert, et al.. (2021). The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB1 Cannabinoid Receptor. Molecular Cancer Therapeutics. 20(5). 787–802. 27 indexed citations
7.
Ramer, Robert, et al.. (2020). A simple LC-MS/MS method for the simultaneous quantification of endocannabinoids in biological samples. Journal of Chromatography B. 1161. 122371–122371. 21 indexed citations
8.
Ramer, Robert, et al.. (2019). Modulation of the Endocannabinoid System as a Potential Anticancer Strategy. Frontiers in Pharmacology. 10. 430–430. 58 indexed citations
9.
Gock, Michael, Christina Susanne Mullins, Christine Harnack, et al.. (2018). Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line. World Journal of Gastroenterology. 24(33). 3749–3759. 11 indexed citations
10.
Ramer, Robert & Burkhard Hinz. (2017). Cannabinoids as Anticancer Drugs. Advances in pharmacology. 80. 397–436. 54 indexed citations
11.
Ramer, Robert, Sascha B. Fischer, Maria Haustein, Katrin Manda, & Burkhard Hinz. (2014). Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. Biochemical Pharmacology. 91(2). 202–216. 57 indexed citations
12.
Kunz, Manfred, Katrin Marie Driller, Martin Hein, et al.. (2010). Synthesis of Thia‐Analogous Indirubin N‐Glycosides and their Influence on Melanoma Cell Growth and Apoptosis. ChemMedChem. 5(4). 534–539. 24 indexed citations
13.
Ramer, Robert, et al.. (2010). Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells. Pharmaceutical Research. 27(10). 2162–2174. 77 indexed citations
14.
Ramer, Robert, et al.. (2009). Antitumorigenic Effects of Cannabinoids beyond Apoptosis. Journal of Pharmacology and Experimental Therapeutics. 332(2). 336–344. 62 indexed citations
16.
Ramer, Robert & Burkhard Hinz. (2007). Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1. JNCI Journal of the National Cancer Institute. 100(1). 59–69. 183 indexed citations
17.
Ramer, Robert, et al.. (2005). Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42/44 mitogen-activated protein kinases. Biochemical and Biophysical Research Communications. 338(2). 1171–1178. 40 indexed citations
18.
Hinz, Burkhard, et al.. (2004). Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells. Molecular Pharmacology. 66(6). 1643–1651. 88 indexed citations
19.
Ramer, Robert, et al.. (2003). Ceramide Is Involved in R(+)-Methanandamide-Induced Cyclooxygenase-2 Expression in Human Neuroglioma Cells. Molecular Pharmacology. 64(5). 1189–1198. 54 indexed citations
20.
Hinz, Burkhard, Robert Ramer, & Kay Brune. (2003). Induction of COX-2 Expression by the Endocannabinoid Derivative R(+)-Methanandamide. Advances in experimental medicine and biology. 525. 145–152. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026